BU Researchers Join $100 Million Effort to Fight Future Deadly Pathogens
Scientists from NEIDL and medical and dental schools part of Howard Hughes Medical Institute push to get ahead of pandemics like COVID-19.
NEIDL Researchers Discover New SARS-CoV-2 Weak Spot—Which Could Inspire Improved Vaccines
Nature publishes BU-led COVID study that made international headlines; scientists find viral protein called NSP6, not just spike, responsible for making Omicron less dangerous than past variants.
Why Global COVID Vaccinations Are Dangerously Lagging: Six Things to Know
As Delta variant spreads rapidly, BU-led panel explains why vaccination rollout isn’t keeping pace
BU NEIDL Scientists Featured in NOVA’s Special Coronavirus Episode
Nahid Bhadelia, Ronald Corley, and Robert Davey talk about COVID-19’s spread, how they’re studying it in the lab
Live Coronavirus Research Gets Underway at BU NEIDL
Virologist Robert Davey will screen thousands of drugs for effectiveness against COVID-19 infection
BU Launches Coronavirus Website
Site includes FAQs and latest information available Does Boston University have a coordinated plan for the coronavirus? Yes. With so many uncertainties with a fast-moving situation, BU on Monday launched a new website of frequently asked questions to address some of the most pressing coronavirus issues facing the University community, from housing to academics to […]
BU NEIDL Scientists Join International Coronavirus Research Effort
Gathering on Monday focused on race to stop coronavirus spread, as dozens of infectious disease researchers from Boston are teaming up with Chinese collaborators
Outbreak Experts: What to Expect Next from Coronavirus
Researchers from BU’s National Emerging Infectious Diseases Laboratories explain how the virus “jumped” from animals to humans and how lethal it might prove to be Airports in China and around the world are screening travelers for signs of infection with the new coronavirus. Photo by Kevin Frayer/Getty Images. The world has been on high alert since […]
New Targets to Treat Type 1 Diabetes
Chemist Arturo Vegas wins $1.4 million NIH grant to develop therapies that intervene at early stage of disease Arturo Vegas wants to create novel therapies that will either suppress rogue immune cells attacking the pancreas of people with type 1 diabetes or strengthen the pancreas’ defenses against the rogue cells. Photo courtesy of Arturo Vegas. […]